BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 569.33% | 176.36% | |||
| Depreciation & Amortization | 2,538.10% | -30.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 582.47% | 149.50% | |||
| Operating Income | -582.47% | -152.24% | |||
| Income Before Tax | -627.43% | -154.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -627.43% | -154.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 66.67% | -- | |||
| Net Income | -624.47% | -155.87% | |||
| EBIT | -582.47% | -152.24% | |||
| EBITDA | -568.55% | -156.98% | |||
| EPS Basic | -443.06% | -107.67% | |||
| Normalized Basic EPS | -406.62% | -107.55% | |||
| EPS Diluted | -443.06% | -107.67% | |||
| Normalized Diluted EPS | -406.62% | -107.55% | |||
| Average Basic Shares Outstanding | 33.28% | 21.15% | |||
| Average Diluted Shares Outstanding | 33.28% | 21.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||